Gregory A McClelland

Title: Innovations of Gregory A McClelland

Introduction

Gregory A McClelland is a notable inventor based in Lawrence, Kansas, who has made significant contributions to the field of drug delivery systems. With a total of five patents to his name, McClelland's work focuses on innovative processes and devices that enhance the efficacy of pharmaceuticals.

Latest Patents

One of McClelland's latest patents is the "Spheronization process using charged resins." This invention outlines a novel method for the spheronization of charged resins, resulting in spherical multiparticulates that range in size from 0.3 mm to 3 mm in diameter. The product produced is microcrystalline-free, and the process involves mixing, wet granulation, spheronization, and drying. Another significant patent is the "Swelling modulated polymeric drug delivery device." This controlled release device is made from swellable polymers, with the degree of swelling regulated by blending swelling modulators within the polymers. These modulators can include buffers, osmagents, and surfactants, which are either surrounded by a microporous coating or interspersed within individual matrices. This innovative combination allows for the regulation of drug release patterns.

Career Highlights

Gregory A McClelland is currently employed at Merck & Company, Inc., where he continues to develop groundbreaking technologies in the pharmaceutical industry. His work has been instrumental in advancing drug delivery systems, making medications more effective and patient-friendly.

Collaborations

Some of McClelland's notable coworkers include Gaylen M Zentner and Stefano A Pogany, who have collaborated with him on various projects within the company.

Conclusion

Gregory A McClelland's contributions to the field of drug delivery through his innovative patents highlight his expertise and commitment to improving pharmaceutical technologies. His work continues to influence the industry and enhance patient care.